Predictive Value of Fasting Blood Glucose for Microvascular Obstruction in Nondiabetic Patients with ST-Segment Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention

Table 1

Baseline clinical characteristics of the participants.

	Non-MVO (N = 31)	MVO (N = 77)	value
Age, years	62.4 ± 11.7	60.1 ± 12.7	0.379
Male, n (%)	24 (77.4)	70 (90.9)	0.109
Hypertension, n (%)	15 (48.4)	38 (49.4)	0.928
Preinfarction angina	11 (35.5)	18 (23.4)	0.199
Smoking, n (%)	17 (54.8)	45 (58.4)	0.732
Body mass index, kg/m^2	24.7 ± 2.7	24.8 ± 3.1	0.830
Systolic blood pressure, mmHg	133.4 ± 24.4	127.7 ± 25.6	0.291
Diastolic blood pressure, mmHg	83.5 ± 10.2	84.2 ± 13.1	0.788
Heart rate, beats per min	79.9 ± 14.5	78.1 ± 16.2	0.600
Killip class, n (%)			0.215
I	29 (93.5)	68 (88.3)	—
II	1 (3.3)	6 (7.8)	—
III	1 (3.3)	0 (0.0)	—
IV	0 (0.0)	3 (3.9)	—
Symptom onset to balloon time, hours	4.8 (3.0–8.0)	5.0 (3.5–8.0)	0.835
Creatinine, μmol/L	72.5 ± 18.6	71.6 ± 14.5	0.796
CRP	4.8 (3.2–9.4)	6.3 (3.7–14.8)	0.181
Total cholesterol, mmol/L	4.2 ± 0.8	4.1 ± 0.8	0.797
HDL, mmol/L	1.0 ± 0.3	1.0 ± 0.3	0.894
LDL, mmol/L	2.5 ± 0.7	2.5 ± 0.7	0.959
FBG, mmol/L	5.2 ± 0.6	6.0 ± 1.8	0.010
HbA1c, %	5.8 ± 0.5	6.0 ± 1.1	0.264
Peak TnT, μg/L	2.6 (1.5–3.7)	6.7 (4.2–10.0)	<0.001
BNP, pg/mL	33.1 (19.0–104.0)	65.9 (24.1–209.8)	0.356

MVO, microvascular obstruction; CRP, C-reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; FBG, fasting blood glucose; HbA1c, hemoglobin A1c; TnT, troponin T; BNP, B-type natriuretic peptide.